pre-seed
Stage
About
Breakthru Medicine is a preclinical biotechnology company developing targeted therapies for genomically defined cancers using multiple independent programs and platform technologies to address critical unmet clinical needs.
Explore Breakthru Medicine's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.